← Open Payments lookup

MICHELLE GULLY: Open Payments

NPI 1801557947 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,141 in 90 payments from 16 companies in 2025. Trend: 2023 $839 · 2024 $1,148 · 2025 $2,141

Food & beverage: $2,141
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.16$406
AstraZeneca Pharmaceuticals LP11$337
Lilly USA, LLC8$251
Kowa Pharmaceuticals America, Inc.17$236
Amgen Inc.6$175
GlaxoSmithKline, LLC.7$161
Novo Nordisk Inc8$154
Exact Sciences Corporation4$102
Xeris Pharmaceuticals, Inc.4$91
Madrigal Pharmaceuticals3$78

Products named: Kerendia, ZORYVE, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, ZEPBOUND, REPATHA, MOUNJARO.

Industry payments across CA — which companies pay providers there.